Company Filing History:
Years Active: 1997
Title: Jeffrey Alan Stafford: Innovator in Pyrrolidine Compounds
Introduction
Jeffrey Alan Stafford is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on novel pyrrolidine compounds. His innovative approach has the potential to impact the treatment of various diseases.
Latest Patents
Stafford holds a patent for "Substituted pyrrolidines." This patent discloses novel pyrrolidine compounds that are useful for inhibiting the function of Type IV phosphodiesterase (PDE-IV). The applications of these compounds extend to treating inflammatory diseases and other conditions involving elevated levels of cytokines, as well as central nervous system (CNS) disorders.
Career Highlights
Throughout his career, Stafford has been associated with Glaxo Wellcome Inc., where he has focused on developing therapeutic solutions. His work has been instrumental in advancing the understanding of pyrrolidine compounds and their applications in medicine.
Collaborations
One of his notable collaborators is Paul L Feldman, with whom he has worked on various projects related to his patent.
Conclusion
Jeffrey Alan Stafford's contributions to the field of medicinal chemistry through his innovative work on pyrrolidine compounds highlight his role as a significant inventor. His research has the potential to lead to advancements in the treatment of various diseases.